Drugs with this side effect
- 5-ASA: postmarketing, rare, 0.7% - 50%
- AMD3100: common, 0% - 7%
- CAS 76095-16-4
- Cancidas
- Colimycin M
- Estrofem
- Fe(III
- Goserelin: 1-10%
- Implanon: postmarketing
- K779
- Kaluril
- L-Dmp
- LY146032: postmarketing, common
- Leuprorelin
- LiOH
- Lisinopril: 0.3% - 0.5%
- Lu AA21004: 1% - 3%
- Meropenem anhydrous
- Metrodin: 0% - 8.8%
- Octreotide: very common, 0.5% - 13.2%
- Oestrogen: 5% - 9%
- Paroven
- Photofrin II: uncommon
- Saxagliptin
- Stalevo 50
- Supremon
- Triptorelin
- Trisequens
- UDCA: 4.66% - 7.74%
- VACV: 0% - 1.8%
- Vancocine
- acamprosate: 1% - 4%
- acarbose
- acebutolol: 1% - 7%
- acyclovir
- adefovir: 4%
- adefovir dipivoxil: postmarketing, common, 4%
- alendronate: 0% - 4.1%
- allopurinol
- alosetron
- alvimopan
- amiloride
- amlodipine
- amlodipine besylate
- amoxapine
- amoxicillin
- amphotericin B
- amprenavir: very common
- anagrelide: 10.2% - 11%
- aprepitant: 4.1% - 5.8%
- aripiprazole
- atazanavir: uncommon
- atomoxetine: 2%
- atorvastatin: 1.1% - 2.8%
- auranofin
- axitinib
- azithromycin: postmarketing, 5% - 10.7%
- baclofen
- balsalazide: 1.93% - 2%
- benazepril
- bepridil
- bexarotene: common, 10%
- bezafibrate: 4.5%
- bicalutamide: 5% - 7%
- bicarbonate
- boceprevir: common
- bortezomib
- bosentan
- brinzolamide
- budesonide: 2.35% - 8.28%
- bupivacaine: 2.36% - 2.43%
- buprenorphine
- bupropion: postmarketing, frequent, 1.8% - 6%
- buspirone: infrequent
- butorphanol: infrequent
- cabergoline: 1.3% - 2%
- capecitabine
- carbenicillin
- carbidopa
- carvedilol
- cefaclor
- cefazolin
- cefdinir
- cefditoren
- cefixime: 3%
- cefpodoxime
- ceftriaxone
- cefuroxime
- cefuroxime axetil
- celecoxib: 2.2% - 4.1%
- cephem
- cerivastatin: 2.1%
- cetirizine
- cevimeline
- chloride
- cidofovir
- cilazapril
- cilostazol: 2% - 3%
- cimetidine: common
- ciprofloxacin: postmarketing, uncommon
- citalopram: frequent, 1.7% - 2%
- cladribine: common, 1%
- clarithromycin: uncommon
- clindamycin
- clindamycin phosphate
- clomipramine: 6%
- clonazepam
- clopidogrel: postmarketing, uncommon
- cobicistat: common
- colesevelam: 12%
- colestimide: common
- colestipol
- colestyramine: common
- conjugated estrogens
- copolymer 1
- cyclobenzaprine
- dabigatran etexilate
- dalteparin
- darifenacin
- darunavir: 2.42% - 3.05%
- delavirdine
- deprenyl: frequent, 2%
- desmopressin
- diclofenac: common, 2% - 3.84%
- dicloxacillin: common
- didanosine: postmarketing
- diflunisal
- diltiazem
- dipyridamole: 0.6%
- disopyramide
- dolasetron
- dolutegravir
- donepezil: infrequent
- doxazosin: 1% - 1.4%
- doxepin
- doxorubicin: common
- duloxetine: postmarketing, uncommon, frequent
- efavirenz: 0% - 2%
- eletriptan: infrequent
- eliglustat: 10%
- elvitegravir: uncommon
- entacapone: 2%
- eplerenone: uncommon
- eprosartan
- erlotinib
- ertapenem
- esomeprazole magnesium
- estazolam: infrequent
- estradiol: postmarketing, 1% - 7%
- estramustine: 0% - 2%
- estramustine phosphate
- etidronate
- etodolac
- etoricoxib
- etravirine
- everolimus: common
- exenatide: postmarketing, uncommon, 2%
- ezetimibe: 1% - 1.1%
- famciclovir: 0.2% - 4.8%
- febuxostat: uncommon
- felbamate
- felodipine
- fenofibrate: common, 0.533% - 2.1%
- fenoprofen
- fentanyl
- fesoterodine
- fexofenadine
- fidaxomicin
- flecainide
- fluconazole
- fluoxetine: 3% - 7.2%
- flurbiprofen
- fluvastatin: 0.8% - 2.6%
- fluvoxamine: infrequent, 4%
- folate
- fosamprenavir: common
- fosaprepitant
- fosaprepitant dimeglumine: 4.1% - 5.8%
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril
- fosinoprilat
- fosphenytoin: infrequent
- frovatriptan: infrequent
- fusidic acid: 1% - 1.6%
- gabapentin: frequent, 1.7% - 14%
- gadofosveset
- gadolinium
- gadoversetamide
- galantamine: frequent
- ganciclovir: 1.7%
- gatifloxacin
- gemfibrozil: 1.5% - 5.3%
- gemifloxacin
- gliclazide
- glipizide: 3.2%
- glutamine: 22.2% - 25%
- glycerol phenylbutyrate: 2.22% - 13.6%
- glycopyrrolate
- gonadorelin: 3.95% - 6.98%
- granisetron: 3%
- hydrochlorothiazide
- hydromorphone
- ibandronate
- ibuprofen: 7.46% - 16.1%
- icodextrin
- imatinib: common, 0% - 34%
- indapamide
- indinavir
- indomethacin
- iohexol
- ipratropium bromide: common
- irbesartan: uncommon
- irbesartan-hydrochlorothiazide
- irinotecan: 0% - 12.2%
- isomannide
- isosorbide-5-mononitrate
- itraconazole
- ketoconazole
- ketoprofen
- ketorolac
- ketorolac tromethamine: postmarketing
- lacosamide
- lactulose
- lamivudine
- lamotrigine
- lanreotide: 0% - 13.5%
- lansoprazole: 1.2% - 2.6%
- lasofoxifene: uncommon
- leflunomide
- lenalidomide: common
- leuprorelin acetate
- levodopa/carbidopa
- levonorgestrel
- linaclotide
- linezolid
- liraglutide: postmarketing
- lithium
- lithium carbonate
- lomefloxacin
- lomitapide
- loperamide: postmarketing
- losartan
- lovastatin: 3.7% - 4.5%
- lubiprostone: 3% - 6%
- lurasidone
- mannitol
- maraviroc
- mefenamic acid
- megestrol: 0% - 10%
- megestrol acetate
- melatonin
- meloxicam: 0.4% - 5.5%
- memantine
- meropenem
- mesna
- metformin: very common, 12.1%
- methyldopa
- methylnaltrexone: very common
- metoprolol: postmarketing, common
- metronidazole
- midodrine
- miglitol
- miglustat: 0% - 50%
- milnacipran
- mirtazapine
- misoprostol: 2.9%
- modafinil
- mometasone furoate
- morphine
- moxifloxacin
- mycophenolate mofetil: 0% - 15.6%
- mycophenolic acid: 10% - 13%
- nabumetone: 6%
- nadolol
- naltrexone
- naproxen: postmarketing
- nefazodone
- nelfinavir: common, 0% - 5%
- neostigmine: postmarketing
- niacin: postmarketing
- nicotine: 2.7% - 4%
- nifedipine: 1.5%
- nilotinib: common
- nisoldipine
- nitazoxanide
- nitrofurantoin: 1.5%
- nizatidine: 4.9%
- norfloxacin: postmarketing
- ofloxacin
- olanzapine: frequent, 1% - 2%
- olsalazine
- omeprazole: common, 2.3% - 10.3%
- ondansetron
- orlistat: 2.1% - 23.9%
- oxaliplatin: 3% - 6%
- oxaprozin
- oxcarbazepine
- oxybutynin: 1.2% - 2.5%
- oxycodone
- oxymorphone
- paclitaxel
- paliperidone
- palonosetron
- pantoprazole: postmarketing, common, 0% - 4%
- parecoxib
- paroxetine: common, 1% - 8%
- pazopanib
- penciclovir: 0.2% - 4.8%
- pentosan polysulfate
- pentostatin
- pentoxifylline: 0.6% - 9%
- pergolide: infrequent
- perindopril
- perindopril erbumine
- phenytoin: infrequent
- pilocarpine
- pindolol
- pioglitazone
- pirfenidone
- piroxicam: 5.2%
- polyoxyethylene
- posaconazole
- potassium
- pramipexole: 1%
- pravastatin: 1.2% - 3.3%
- pregabalin: 0% - 3%
- progesterone
- propafenone: 0% - 2.38%
- prostacyclin
- prucalopride: common
- pyridostigmine
- quetiapine: infrequent, 1%
- quinapril
- quinaprilat
- rabeprazole
- raloxifene: 1.6% - 6.4%
- raltegravir
- ranolazine
- rapamycin
- rasagiline
- retinoic acid
- ribavirin: common
- rifabutin: 2%
- rifampicin
- rifaximin: 11.2%
- riluzole: 1.8% - 2.6%
- risedronate: rare, 1.5% - 2.6%
- risperidone: infrequent
- ritonavir: 0.8% - 2.6%
- rivastigmine: frequent, 4%
- rizatriptan: infrequent
- rofecoxib
- ropinirole: infrequent, 2% - 3%
- rosuvastatin
- roxithromycin
- ruxolitinib: common, 0% - 5.2%
- salbutamol: 2%
- salmon calcitonin acetate
- saquinavir: common
- sertraline: 4%
- sevelamer: 8%
- sevelamer carbonate: 8%
- sevelamer hydrochloride: 4% - 8%
- sibutramine
- sildenafil
- simvastatin: 0.9% - 14.5%
- sitagliptin: postmarketing
- sodium cromoglycate
- sodium ferric gluconate
- sotalol: 1% - 2%
- sparfloxacin: 1.1%
- stavudine
- strontium ranelate: postmarketing
- sulindac
- sumatriptan: rare
- sunitinib
- tacrolimus: common
- tegaserod: 6%
- telavancin: uncommon
- telithromycin: 0.9% - 1.4%
- telmisartan: rare, uncommon
- tenofovir: 3% - 4%
- tenofovir disoproxil fumarate: postmarketing, common, 3% - 4%
- terazosin
- terbinafine: very common, 0% - 2.2%
- tetraen
- thalidomide: 0% - 8.33%
- tiagabine
- tiaprofenic acid: 1.5% - 2.2%
- ticlopidine
- tigecycline
- tinidazole
- tiopronin
- tipranavir: common
- tizanidine: infrequent
- tolcapone: 2%
- tolmetin
- tolterodine: 1.3%
- topiramate: 1%
- tramadol: uncommon
- trandolapril
- trazodone
- triazolam
- trospium chloride: 1.18% - 1.56%
- trovafloxacin
- v 1784: postmarketing, 4% - 5%
- valdecoxib: 2.9% - 7.7%
- valganciclovir
- valproate
- valrubicin
- valsartan
- varenicline: 6% - 9%
- venlafaxine: 4%
- vilazodone: 3%
- vildagliptin: uncommon
- vinflunine
- voriconazole
- warfarin
- zalcitabine
- zaleplon: infrequent
- zidovudine: postmarketing, uncommon
- zidovudine/lamivudine
- zileuton
- ziprasidone: uncommon
- zolpidem: infrequent, 1%
- zonisamide: infrequent
- zuclopenthixol
|
Drugs with this indication
|
